Try our Advanced Search for more refined results
December 12, 2012
FTC v. Boehringer Ingelheim Pharmace
Case Number:
12-5393
Court:
Nature of Suit:
Companies
Government Agencies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 07, 2015
Boehringer Asks DC Circ. To Rethink Doc Ruling In FTC Probe
Boehringer Ingelheim Pharmaceuticals Inc. asked the D.C. Circuit on Monday for another shot at defending a lower court order that largely rejected the Federal Trade Commission's documents request in its investigation into an alleged Aggrenox pay-for-delay deal, arguing the circuit court's ruling slashed work product protections.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login